Audit of initial management of congenital hypothyroidism in the United Kingdom - Comparison of UK practice with European and UK guidelines

Journal of Pediatric Endocrinology and Metabolism

Volumn 22, Issue 11, 2009, Pages 1017-1025

  Jones, Jeremy Huw ^a   Donaldson, Malcolm D C ^a  

^a ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

Author keywords

Congenital hypothyroidism; Infant; Newborn; Practice guidelines; Screening

Indexed keywords

EVOTROX; THYROXINE; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL PRACTICE; CONGENITAL HYPOTHYROIDISM; DRUG PREFERENCE; EUROPE; FOLLOW UP; HEALTH SERVICES RESEARCH; HORMONE SUBSTITUTION; LIQUID; MEDICAL AUDIT; PATIENT REFERRAL; PRACTICE GUIDELINE; SHELF LIFE; TABLET FORMULATION; UNITED KINGDOM;

EID: 75749101449     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2009.22.11.1017     Document Type: Article

References (12)

1. Selva K, Harper A, Downs A, Blasco PA, LaFranchi SH. Neurodevelopmental outcomes in congenital hypothyroidism: comparison of initial T4 dose and time to reach target T4 and TSH. J Pediatr 2005; 147: 775-780.
2. Bongers-Schokking JJ, Koot HM, Wiersma D, Verkerk PH, de Muinck Keizer-Schrama SMPF. Influence of timing and dose of thyroid hormone replacement on development in infants with congenital hypothyroidism. J Pediatr 2000; 136: 292-297.
3. Working Group on Neonatal Screening of the European Society for Paediatric Endocrinology. Revised guidelines for neonatal screening programmes for primary congenital hypothyroidism. Horm Res 1999; 52: 49-52.
4. UK Newborn Screening Programme Centre. Newborn blood spot screening in the UK. Policies and Standards. 2005. http://www.newbornscreening-bloodspot.org. uk.
5. Jones JH, Mackenzie J, Croft GA, Beaton S, Young D, Donaldson MDC. Improvement in screening performance and diagnosis of congenital hypothyroidism in Scotland 1979-2003. Arch Dis Child 2006; 91: 680-685.
6. LaFranchi SH, Austin J. How should we be treating children with congenital hypothyroidism? J Pediatr Endocrinol Metab 2007; 20; 559-578.
7. Nelson JC, Clark SJ, Borut DL, Tomei RT, Carlton EI. Age-related changes in serum free thyroxine during childhood and adolescence. J Pediatr 1993; 123: 899-905.
8. Léger J, Larroque B, Norton J. Influence of severity of congenital hypothyroidism and adequacy of treatment on school achievement in young adolescents: a population-based cohort study. Acta Paediatr 2001; 90: 1249-1256.
9. Hindmarsh PC. Optimisation of thyroxine dose in congenital hypothyroidism. Arch Dis Child 2002; 86: 73-75.
10. Jones JH, Gellen B, Paterson WF, Beaton S, Donaldson MDC. Effect of high versus low initial doses of L-thyroxine for congenital hypothyroidism on thyroid function and somatic growth. Arch Dis Child 2008; 93: 940-944.
11. Mathai S, Cutfield WS, Gunn AJ, Webster D, Jefferies C, Robinson E, Hofman P. A novel therapeutic paradigm to treat congenital hypothyroidism. Clin Endocrinol 2008; 69: 142-147.
12. Korada M, Kibirige M, Turner S, Day J, Johnstone H, Cheetham T. The implementation of revised guidelines and the performance of a screening programme for congenital hypothyroidism. J Med Screen 2008; 15: 5-8.